IRIS
PEPE, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.688
EU - Europa 830
AS - Asia 351
AF - Africa 28
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 2.907
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.667
UA - Ucraina 283
SG - Singapore 210
IT - Italia 193
CN - Cina 124
FI - Finlandia 81
DE - Germania 77
NL - Olanda 69
IE - Irlanda 59
SE - Svezia 31
CI - Costa d'Avorio 28
GB - Regno Unito 26
CA - Canada 21
VN - Vietnam 8
FR - Francia 7
IN - India 6
AU - Australia 4
EU - Europa 3
BR - Brasile 2
CH - Svizzera 2
TR - Turchia 2
CL - Cile 1
ES - Italia 1
JO - Giordania 1
RS - Serbia 1
Totale 2.907
Salva come PNG Salva come JPEG
Città #
Jacksonville 263
Woodbridge 231
Chandler 184
Singapore 166
Millbury 115
Princeton 76
Ashburn 75
Ann Arbor 74
Amsterdam 66
Wilmington 44
Houston 43
Santa Clara 42
Nanjing 32
Beijing 29
Ottawa 20
Milan 16
Boston 15
Seattle 15
Shenyang 15
Cagliari 12
Nanchang 11
Norwalk 10
Orange 10
Naples 9
Napoli 9
Dong Ket 8
Washington 8
Boardman 7
Hebei 7
Rome 7
Casoria 6
Falls Church 5
Indiana 5
Kronberg 5
Kunming 5
Munich 5
Castellammare di Stabia 4
Des Moines 4
Helsinki 4
Jiaxing 4
Lawrence 4
Los Angeles 4
Pune 4
Sydney 4
Catania 3
Dublin 3
New York 3
Redmond 3
Tianjin 3
Turin 3
Ancona 2
Avellino 2
Bareggio 2
Changsha 2
Florence 2
Frankfurt am Main 2
Heidelberg 2
Kolkata 2
Mountain View 2
Parnamirim 2
Perugia 2
Pozzallo 2
Rapolla 2
San Francisco 2
Springfield 2
Walnut 2
Zurich 2
Amman 1
Andover 1
Augusta 1
Belgrade 1
Bologna 1
Bonate Sopra 1
Castelnuovo Rangone 1
Castelvetrano 1
Changchun 1
Costa Masnaga 1
Dallas 1
Eindhoven 1
Fairfield 1
Ferrara 1
Fort Worth 1
Friesland 1
Fuzhou 1
Giugliano In Campania 1
Guangzhou 1
Islington 1
La Canada Flintridge 1
Leawood 1
Lecce 1
Leeds 1
Lyon 1
Modena 1
Montegrotto Terme 1
Mugnano di Napoli 1
Newark 1
Piemonte 1
Poggiomarino 1
Porto Sant'elpidio 1
Rivarolo Canavese 1
Totale 1.767
Salva come PNG Salva come JPEG
Nome #
Manuale di Oncologia Clinica 101
Critical role of both p27kip1 and p21cip1/waf1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. 62
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 62
Società Italiana di Citofluorimetria (GIC) 61
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-a genes on in vitro transformation of human mammary epithelial cells. 57
Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. 56
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors. 52
Breast cancer prevention with fenretinide in young women at gentic and familial risk. A phase III randomized clinical trial 51
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 50
Enzastaurin inhibits tumors sensitive and resistant to anti-EGFR drugs 50
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide. 48
BRAF is a therapeutic target in aggressive thyroid carcinoma. 48
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells. 48
Epidermal growth factor (EGFR) and Transferrin (TRFR) receptor upregulation is induced by arabinoside cytosine (ARA-C) on human tumor cells. 47
Antisense-protein kinase A: a single-gene-based therapeutic approach. 47
DNA index of ovarian carcinomas from 56 different patients: in vivo, in vitro studies. 47
Mitozolomide activity on human cancer cells "in vitro". 46
Phorbol-12-myristate-13-acetate (PMA) induces resistance of human melanoma cells to NK and LAK-mediated cytotoxicity. 45
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the b1 integrin profile of cultured human tumor cells. 45
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. 45
Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells. 44
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling 44
cAMP-dependent protein kinase: role in normal and malignant growth. 43
Malignant melanoma Clustering with some familial/hereditary tumors 43
The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. 42
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells. 42
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 41
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study. 41
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway death is antagonized by epidermal growth factor. 40
Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. 40
In vitro and in vivo cytotoxicity of possible uracil metabolites of methylxanthines. 40
Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. 40
Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54p53wt and U251p53mut glioblastoma cell lines. 39
p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. 39
Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells. 39
Recombinant IFN-alfa 2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells. 39
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. 39
Synergistic anti-tumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells. 38
Hereditary and familial breast and ovarian cancer: spectrum of related tumors. 38
In vitro cytotoxicity of VP-16213 on human ovarian cancer. 37
TGFb inhibits rat thyroid cell proliferation without alterations in the expression of THS-induced cell cycle-related genes. Vol :pp , 37
Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment. 37
NM23 gene expression correlates with cell growth rate and S-phase. 37
Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting Protein Kinase A in combination with docetaxel and anti-EGFR-Receptor antibody on human breast cancer cell growth. 37
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. 36
Flow cytometric analysis of DNA content in human ovarian cancer. 36
Markers of cell proliferation as prognostic factors in differentiated thyroid cancer. 36
Quality control for the evaluation of the S-phase fraction by flow cytometry: a multicentric study. 36
The cancer spectrum related to hereditary and familial breast and ovarian cancers 35
Regulation of the expression of the low-affinity IgE receptor (FceRII) in the human monocyte-like cell line U-937 by phorbol esters and IgE. 34
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. 34
Loss of thyrotropin regulation and trasforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells. 34
Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells. 33
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype 33
EGF activates an inducible survival response via the RAS -> Erk-1/2 pathway to counteract interferon-alfa-mediated apoptosis in epidermoid cancer cells. 33
Retrospective Analysis of Familial Clustering for Malignant Melanoma 33
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-A in head and neck cancer cells in vitro and in vivo 32
Correlation between bevacizumab-related hypertension and response in mCRC patients 30
A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. 29
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A. 27
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up. 27
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 27
null 26
Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents. 26
Studio osservazionale sorveglianza diagnostica di donne ad alto rischio genetico-familiare di tumore mammario (ISSIN-HIBCR) 26
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 26
Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits. 24
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014 24
The cAMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 23
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase C beta inhibitor, in non-small cell lung cancer cells. 23
POLY (ADP-RIBOSE) POLYMERASE (PARP-1) EXPRESSION IN MALIGNANT MELANOMAS FROM PHOTO EXPOSED AREAS OF THE HEAD AND NECK REGION 23
8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells 22
New biomolecular prognostic and predictive factors of response to treatments in colorectal cancer 22
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 22
Le neoplasie eredo-familiari della mammella, dell'ovaio e del colon retto. Aspetti clininci, diagnostici e teraputici. 21
Differential effects of type I and type II protein kinase A isoforms on chinese hamster ovary cell cycle and proliferation. 19
Fine needle cytology, infectious diseases and non-Hodgkin lymphoma 19
Phase I clinical study with 8-Chloro-cAMP and evaluation of immunological effects in cancer patients. 18
Retroviral vector-mediated overexpression of the RIIbeta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts. 15
The RIalfa subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. 14
TSH-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cAMP-dependent protein kinase 12
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. 2
Totale 3.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.133
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020120 0 0 0 0 0 2 1 1 0 18 25 73
2020/2021479 4 54 59 58 57 53 60 2 61 4 53 14
2021/2022434 8 1 2 1 2 23 3 17 61 42 112 162
2022/2023469 85 41 14 18 49 54 7 33 59 71 34 4
2023/2024423 13 61 29 44 28 47 10 82 0 11 66 32
2024/2025277 96 105 12 18 46 0 0 0 0 0 0 0
Totale 3.016